Skip to main content
eedwswebxuwtbzeby

Wallace H. Coulter Foundation

Profile

Last Updated: 2016-06-06

At A Glance

Wallace H. Coulter Foundation

790 N.W. 107th Ave., Ste. 215

Miami, FL United States 33172-3158

Telephone: (305) 559-2991

URL: www.whcf.org

Type of Grantmaker

Independent foundation

Financial Data

(yr. ended 2014-12-31)

Assets: $221,011,831

Total giving: $24,550,891

EIN

311546126

BRIDGE Number

7948933214

Background

Established in 2000 in DE and FL - Founded by the late Wallace H. Coulter to fund improvements in health care through medical research and engineering. Coulter was an engineer, inventor, and entrepreneur who applied engineering principles to a biomedical problem, resulting in the discovery of the "Coulter Principle." He founded the Coulter Corporation (now Beckman Coulter, Inc.), a medical diagnostics company, which developed and marketed the first automated blood cell counters and flow cytometers.

Purpose and Activities

The foundation is dedicated to improving human health care by supporting translational research in biomedical engineering-research directed at the transfer of promising technologies within the university research laboratory that are progressing towards commercial development and clinical practice.

Program Area(s)

The grantmaker has identified the following area(s) of interest:

Early Career Awards in Biomedical Engineering

The awards are designed to support biomedical engineering research that is translational in nature, and to encourage and assist eligible biomedical engineering investigators as they establish themselves in academic research careers that involve translational research. The foundation invites applications from principal investigators (PIs) who meet the following eligibility criteria: 1) The Pl must be a full-time tenure-track faculty member, or equivalent, with a primary appointment in a Biomedical Engineering Department (or other similarly constituted, permanently established biomedical/bio-engineering academic program) at a North American university; 2) The Pl must have received his or her doctoral degree no more than six years prior to submitting the application for this award; and 3) The Pl must not hold an academic rank higher than Assistant Professor, or equivalent, at the time of application submission. Because of the nature of the research supported by this award, collaboration between the Biomedical Engineering PI and a clinical investigator affiliated with a practicing clinical environment is required. Practicing clinicians often bring a sense of urgency, relevancy, and practicality to a biomedical engineering research project that enhances the translational process. The collaboration may take a number of different forms, including the clinical investigator, being a co-investigator in the research or a consultant to the project, but in any event, he/she must be involved in a substantive capacity. Each award will be for two years for an amount not to exceed $100,000 per year. The second year of funding will be contingent upon adequate progress during the first year.

Program-Related Investment

The foundation has made a PRI, in the form of a direct equity investment, to a pharmaceutical company to conduct research relating to the control of hemorrhage and for the treatment of bleeding disorders, to provide substantial benefit to vicitims of battlefield and other trauma injuries.

Translational Partnership Program

Through this program, the foundation will form working partnerships with leading biomedical engineering programs at North American universities, and will work closely with the selected partner institutions to promote, develop and realize the clinical potential of translational research activities within those institutions and their communities. The goals of this program are to: 1) Fund promising biomedical engineering translational research projects; 2) Increase and support effective collaborations between biomedical engineering researchers and clinical investigators; 3) Increase awareness of the importance of moving promising technologies from the academic laboratory to product commercialization and clinical use; and 4) Develop and support sustainable programs and processes that will increase, enhance, and accelerate this movement. To accomplish these goals, the foundation will develop partnerships with certain select institutions, and their biomedical engineering programs, which share these goals and possess the desire, commitment, and infrastructural resources to ensure their achievement. The foundation's financial commitment to each selected partner institution will include: an annual $580,000 award, renewable for a period of up to five years. The award will be used to support multiple translational research projects involving biomedical engineering faculty and clinical co-investigators. Each partner institution will be considered for a substantial endowment that will be available to sustain the program. The endowment will be given, at the end of the five year award period, to those partners who have exhibited outstanding performance in meeting the program's goals who have made substantial institutional commitments to the program, and who have demonstrated that the award has had a significant institutional impact.

Fields of Interest

Subjects
  • Biomedicine
  • Diseases and conditions
  • Health
  • Medical specialties
  • Nonprofits
  • Science
Population Groups
  • Academics
  • Economically disadvantaged people
  • Low-income and poor people
  • People of Asian descent
Organizations
  • Public charities

Financial Data

Year ended 2014-12-31

Assets: $221,011,831 (market value)

Expenditures: $34,075,090

Total giving: $24,550,891

Qualifying distributions: $31,050,448